Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Ploner Ferdinand |
Präsentationen bei wissenschaftlichen und nicht-wissenschaftlichen Veranstaltungen
Issels, RD; Lindner, LH; Ghadjar, P; Reichardt, P; Hohenberger, P; Verweij, J; Abdel-Rahman, S; Daugaard, S; Salat, C; Vujaskovic, Z; Wessalowski, R; Duerr, HR; Ploner, F; Mella, O; Schmidt, M; Mansmann, U; Jauch, KW; Belka, C; Hiddemann, W; Gronchi, A
Improved overall survival by adding regional hyperthermia to neo-adjuvant chemotherapy in patients with localized high-risk soft tissue sarcoma (HR-STS): Long-term outcomes of the EORTC 62961/ESHO randomized phase III study
EUR J CANCER. . 2015; 51: S716-S716.-European Cancer Congress; 2015; Vienna, AUSTRIA.
Doi: 10.1016/S0959-8049(15)30071-X
[Oral Communication]
Web of Science
FullText
FullText_MUG
Kump, PK; Spindelböck, W; Suppan, C; Ploner, F; Wießpeiner, U; Krejs, GJ; Lipp, R
53-jähriger Patient mit symptomatischem Ileocökalem Neuroendokrinem Tumor:14 Jahre Follow-Up sequentieller antiproliferativer Therapieoptionen
32. Jahrestagung der ACO-ASSO 2015 ; OCT 1-3, 2015; St. Wolfgang (Salzkammergut), AUSTRIA. 2015.
[Poster]
Mir, O; Brodowicz, T; Wallet, J; Italiano, A; Le Cesne, A; Blay, JY; Ryckewaert, T; Bertucci, F; Piperno-Neumann, S; Ploner, F; Toulmonde, M; Domont, J; Saada, E; Delcambre, C; Isambert, N; Delaine, SC; Taieb, S; Lindner, E; Lieg-Atzwanger, B; Penel, N
Activity of regorafenib (RE) in leiomyosarcomas (LMS) and other types of soft-tissue sarcomas (OTS): Results of a doubleblind, randomized placebo (PL) controlled phase II trial
J CLIN ONCOL. 2015; 33(15):-Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO); MAY 29-JUN 02, 2015; Chicago, IL.
Web of Science
Ploner, F; Liegl-Atzwanger B; Leithner, A
Lipomatosarkome - 3 Fallberichte.
Sarkomkonferenz; Februar 26-28, 2015; Münster, GERMANY. 2015.
[Oral Communication]
Ploner, F; Plank, J; Humer-Fuchs, U; Lax, S; Noggler, P; Rosanelli, G; Stepan, V
Hypoglycaemia in a Patient with Glucagonoma-Coincidence of a Glucagonoma and Insulinoma in a Patient with Multiple Endocrine Neoplasia Type I
NEUROENDOCRINOLOGY. . 2015; 102(1-2):153-153.-12th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease; MAR 11-13, 2015; Barcelona, SPAIN.
[Oral Communication]
Web of Science
Ploner, F; Plank, J; Humer-Fuchs, U; Lax, S; Noggler, P; Rosanelli, G; Stepan, V;
Hypoglycaemia in a patient with Glucagonoma – Coincidence of a Glucagonoma and Insulinoma in a patient with multiple Endocrine Neoplasia Type I
12th Annual ENETS Conference; March 11-13, 2015; Barcelona, Spain. 2015.
[Poster]
Leithner, A; Szkandera, J; Ploner, F; Maurer-Ertl, W; Liegl-Atzwanger, B
Neue Therapieansätze in der Therapie der aggressiven Fibromatose.
Abstractband AMSOS Wien. 2013; -AMSOS Wien; APR 26-27, 2013; Vienna, AUSTRIA.
[Oral Communication]
Szkandera, J; Gerger, A; Liegl-Atzwanger, B; Absenger, G; Stotz, M; Samonigg, H; Maurer-Ertl, W; Stojakovic, T; Ploner, F; Leithner, A; Pichler, M
VALIDATION OF THE PROGNOSTIC RELEVANCE OF PLASMA C-REACTIVE PROTEIN LEVELS IN SOFT TISSUE SARCOMA.
Abstracts of the 18th Annual Meeting CTOS, P 94. 2013; -Connective Tissue Oncology Society 18th Annual Meeting; OCT 30 - NOV 2, 2013; New York, USA.
[Poster]
Szkandera, J; Pichler, M; Liegl-Atzwanger, B; Absenger, G; Stotz, M; Ploner, F; Stojakovic, T; Samonigg, H; Leithner, A; Gerger, A
THE ELEVATED PRE-OPERATIVE PLASMA FIBRINOGEN LEVEL IS AN INDEPENDENT NEGATIVE PROGNOSTIC FACTOR FOR CANCER-SPECIFIC; METASTASIS-FREE AND OVERALL SURVIVAL IN SOFT-TISSUE SARCOMA PATIENTS.
Abstracts of the 18th Annual Meeting CTOS, P 93. 2013; -Connective Tissue Oncology Society 18th Annual Meeting; OCT 30 - NOV 2, 2013; New York, USA.
[Poster]
Dolcet, C; Thalhammer, M; Pfeifer, H; Kohek, P; Langner, C; Schwarz, T; Ploner, F; Mischinger, HJ
Interdisziplinäre Behandlung eines GIST.
27. Jahrestagung der ACO/ASSO; OKT 7-9, 2010; St. Wolfgang, AUSTRIA. 2010.
[Poster]
Dolcet, C; Thalhammer, M; Pfeifer, H; Kohek, P; Langner, C; Schwarz, T; Ploner, F; Mischinger, HJ
Interdisziplinäre Behandlung eines rectalen GIST
27. Jahrestagung der ACO/ASSO; OCT 7-9, 2010; St. Wolfgang, AUSTRIA. 2010.
[Oral Communication]
Maier, A; Neuböck, N; Matzi, V; Lindenmann, J; Husic, A; Ploner, F; Wurm, R; Stranzl-Lawatsch, H; Smolle-Jüttner, FM
Nicht-kleinzelliges Bronchuskarzinom: Resektion als Ziel interdisziplinärer Therapieschemata.
16. wissenschaftliche Sitzung der Wissenschaftlichen Gesellschaft der Ärzte in der Steiermark; JUN 17, 2010; Graz, AUSTRIA. 2010.
[Keynote lecture]
Matzi, V; Dexl, S; Baumgartner, E; Swatek, P; Ploner, F; Kapp, K; Maier, A; Smolle-Jüttner, FM
Oesophaguskarzinom: Stahl, Strahl, Alkylans- oder Licht?
16. wissenschaftliche Sitzung der Wissenschaftlichen Gesellschaft der Ärzte in der Steiermark; JUN 17, 2010; Graz, AUSTRIA. 2010.
[Keynote lecture]
Osprian, I; Pichler, M; Samonigg, H; Ploner, F; Bauernhofer, T;
Third line treatment of relapsed small-cell lung cancer with irinotecan and carboplatin: A case report.
ÖGHO Frühjahrstagung 2010; APRIL 8-10, 2010; Bregenz, Austria. 2010.
[Poster]
Szkandera, J; Ploner, F; Bauernhofer, T; Kasparek, AK; Payer, F; Balic, M; Knechtel, G; Gerger, A; Galle; Samonigg, H; Hofmann, g;
Paraneoplastic limbic encephalitis in a patient with extragonadal chorioncarcinoma - the significance of onconeural antibodies: a case report
MEMO Suppl 01/10; 2010; 20-21.-Frühjahrstagung 2010 der Österreichischen Gesellschaft für Hämatologie und Onkologie; APR 8-10; Bregenz, AUSTRIA .
[Poster]
Auprich, M;Augustin, H;Ruppert, A;Ploner, F;Kronberger, L;Denk, H;Pummer, K;Petritsch, PH;
HARNBLASENMETASTASEN EINES BILATERALEN MAMMAKARZINOMS ALS ERSTMANIFESTATION EINER FERNMETASTASIERUNG: FALLBESCHREIBUNG.
Journal für Urologie und Urogynäkologie2007; 14(S1):11--33. GEMEINSAME TAGUNG DER ÖGU UND DER BAYER. UROLOGENVEREINIGUNG; JUN 14-16, 2007; Salzburg, AUSTRIA.
[Poster]
Leithner, K; Stacher, E; Wurm, R; Ploner, F; Quehenberger, F; Polachova, J; Samonigg, H; Popper, H; Olschewski, H
TRAIL receptors as prognostic factors in non-small cell lung cancer
Scientific Lung Day Graz; APR 28, 2007; Graz, AUSTRIA. 2007.
[Poster]
Leithner, K; Stacher, E; Wurm, R; Ploner, F;Quehenberger, F; Polachova, J; Samonigg, H; Popper, H; Olschewski, H
TRAIL receptors as prognostic factors in non-small cell lung cancer
European Respiratory Journal 2007; 30(S 51):716s-716s.-17th European Respiratory Socienty Annual Congress; SEPT 15-19, 2007; Stockholm, SWEDEN.
[Oral Communication]
Schippinger, W; Lileg, B; Ploner, F; Weitzer, W; Bauemhofer, T; Samonigg, H
Neoadjuvant chemotherapy with non-pegylated liposomal doxorubicin, docetaxel and trastuzumab in HER-2/neu overexpressing breast cancer
ANN ONCOL. 2007; 18: 166-166.
[Poster]
Web of Science
Leithner, K; Stacher, E; Wurm, R; Ploner, F; Quehenberger, F; Polachova, J; Samonigg, H; Popper, H; Olschewski, H
Cytoplasmic staining for survivin is associated with poor chemotherapy response in non-small cell lung cancer (NSCLC).
ÖGP Jahrestagung ; NOV 6-9, 2006; Graz, Austria. 2006.
[Poster]
Leithner, K; Stacher, E; Wurm, R; Ploner, F; Quehenberger, F; Polachova, J; Samonigg, H; Popper, H; Olschewski, H
Expression of death receptor 5 (DR5) as prognostic factor in advanced non-small cell lung cancer (NSCLC)
Jahrestagung der österreichischen Gesellschaft für Lungenheilkunde; NOV 6-9, 2006; Graz, Austria. 2006.
[Oral Communication]
Leithner, K; Stacher, E; Wurm, R; Popper, H; Samonigg, H; Ploner, F; Polachova, J; Olschewski, H
Death receptor 5 and survivin as prognostic markers in advanced NSCLC.
-23rd Annual Meeting of the Austrian Society of Surgical Oncology
(ACO-ASSO) - 11th International Thoracic Surgery Congress; OCT 5-7, 2006; St. Wolfgang, Austria.
[Poster]
Leyvraz, S; Pampallona, S; Martinelli, G; Ploner, F; Aversa, S; Rosti, G; Brunsvig, P; Montes, A; Yilmaz, U; Perey, L
Randomized phase III study of high-dose sequential chemotherapy (CT) supported by peripheral blood progenitor cells (PBPC) for the treatment of small cell lung cancer (SCLC): Results of the EBMT Random-ICE trial.
J CLIN ONCOL. 24(18):380S-380S.
[Poster]
Web of Science
Samonigg, H; Andritsch, E; Dietmaier, G; Bauernhofer, T; Andritsch, H; Zloklikovits, S; Kasparek, AK; Stoeger, H; Schaberl-Moser, R; Ploner, F
Healing by Design: the Influence of an Artistic Design on the Wellbeing of Cancer Patients-- a 10 Years Follow Up.
Journal of Clinical Oncology. 2006 ASCO Annual Meeting Proceedings Part I. (June 20 Supplement); 24(18S):-2006 ASCO Annual Meeting; JUNE 2-6, 2006; Atlanta, USA.
[Poster]
Keeling, IM; Ploner, F; Mächler, H; Rigler, B
Primäre Malignome des Herzens.
Eur Surg 2005; 37 (Suppl. 203): 30.-46. Tagung der ÖGC; 26.-28.5.2005; Vienna, AUSTRIA.
[Oral Communication]
Auprich, M; Augustin, H; Ruppert, A; Ploner, F; Kronberger, L; Denk, H
Bladder metastasis of bilateral breast cancer as first manifestation of metastatic spread: case report.
British Journal of Urology . 2004; 94(s2):302-306.-27th World Congress, Société Internationale dUrologie (SIU); OCT 3-7, 2004; Honululu, USA.
[Poster]
Langsenlehner, U; Eder, T; Wagner, P; Ploner, F; Samonigg, H
Niedrig differenziertes neuroendokrines Karzinom und Flushsymptomatik- eine ungewöhnliche Konstellation mit therapeutischer Option
Kongressband des 50. Ausseer Symposium 2004; -50. Ausseer Symposium; MAY 6-9, 2004; Bad Aussee, AUSTRIA.
[Poster]
Schippinger, W; Bauernhofer, T; Regitnig, P; Ploner, F; Krippl, P; Hofmann, G; Lax, S; Carney, W; Neumann, R; Wernecke, KD; Samonigg, H
Serum HER-2/neu dynamics in metastatic breast cancer as an independent prognostic factor.
BREAST CANCER RES TREAT 2003 82: S123-S123.
Web of Science
Ploner, F; Genser, B; Schippinger, W; Hofmann, G; Samonigg, H
The influence of prognostic factors seems to be constant throughout the course of metastatic breast cancer regardless of therapeutical intervention.
BREAST CANCER RES TREAT. 2002; 76: S48-S48.
Web of Science
Schippinger, W; Bauernhofer, T; Ploner, F; Hofmann, G; Krippl, P; Neumann, R; Wernecke, KD; Samonigg, H
Serum HER-2/neu levels correlate with time to progression in therapy of metastatic breast cancer.
BREAST CANCER RES TREAT 2002 76: S104-S104.
Web of Science
Bauernhofer, T; Schmid, M; Stoeger, H; Kasparek, AK; Ploner, F; Kuss, I; Gilli, R; Lanzer, H; Samonigg, H
Sequential dose intensive chemotherapy with cyclophosphamide and carboplatin (CC) with peripheral blood progenitor cell (PBPC) support in metastatic breast cancer patients.
BONE MARROW TRANSPLANT 1999 23: S37-S37.
Web of Science
Schmid, M; Bauernhofer, T; Resel, M; Ploner, F; Schippinger, W; Gilli, R; Lanzer, G; Truschnig-Wilders, M; Samonigg, H
High-dose chemotherapy with peripheral blood stem cell support for high risk breast cancer.
BONE MARROW TRANSPLANT 1999 23: S42-S42.
Web of Science
Derstvenscheg, E; Stöger, H; Stranzl, H; Bauernhofer, T; Ploner, F; Samonigg, H
Das männl. Mammakarzinom- ein Bericht über 43 Patienten
Acta Chirurgica Austriaca, 28 (125), 1996, p 131996; 28(125):13-13.-Senologiekongress; 17.-19. Oktober 1996; Graz, Österreich.
[Poster]